These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 32823229)

  • 61. Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.
    Sunami K; Bando H; Yatabe Y; Naito Y; Takahashi H; Tsuchihara K; Toyooka S; Mimori K; Kohsaka S; Uetake H; Kinoshita I; Komine K; Takeda M; Hayashida T; Tamura K; Nishio K; Yamamoto N;
    Cancer Sci; 2021 Sep; 112(9):3911-3917. PubMed ID: 34128569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers.
    Sabari JK; Offin M; Stephens D; Ni A; Lee A; Pavlakis N; Clarke S; Diakos CI; Datta S; Tandon N; Martinez A; Myers ML; Makhnin A; Leger Y; Yu HA; Paik PK; Chaft JE; Kris MG; Jeon JO; Borsu LA; Ladanyi M; Arcila ME; Hernandez J; Henderson S; Shaffer T; Garg K; DiPasquo D; Raymond CK; Lim LP; Li M; Hellmann MD; Drilon A; Riely GJ; Rusch VW; Jones DR; Rimner A; Rudin CM; Isbell JM; Li BT
    J Natl Cancer Inst; 2019 Jun; 111(6):575-583. PubMed ID: 30496436
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
    Jee J; Lebow ES; Yeh R; Das JP; Namakydoust A; Paik PK; Chaft JE; Jayakumaran G; Rose Brannon A; Benayed R; Zehir A; Donoghue M; Schultz N; Chakravarty D; Kundra R; Madupuri R; Murciano-Goroff YR; Tu HY; Xu CR; Martinez A; Wilhelm C; Galle J; Daly B; Yu HA; Offin M; Hellmann MD; Lito P; Arbour KC; Zauderer MG; Kris MG; Ng KK; Eng J; Preeshagul I; Victoria Lai W; Fiore JJ; Iqbal A; Molena D; Rocco G; Park BJ; Lim LP; Li M; Tong-Li C; De Silva M; Chan DL; Diakos CI; Itchins M; Clarke S; Pavlakis N; Lee A; Rekhtman N; Chang J; Travis WD; Riely GJ; Solit DB; Gonen M; Rusch VW; Rimner A; Gomez D; Drilon A; Scher HI; Shah SP; Berger MF; Arcila ME; Ladanyi M; Levine RL; Shen R; Razavi P; Reis-Filho JS; Jones DR; Rudin CM; Isbell JM; Li BT
    Nat Med; 2022 Nov; 28(11):2353-2363. PubMed ID: 36357680
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
    Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
    Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung Cancer.
    Schouten RD; Vessies DCL; Bosch LJW; Barlo NP; van Lindert ASR; Cillessen SAGM; van den Broek D; van den Heuvel MM; Monkhorst K
    JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34632253
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression.
    Aldea M; Hendriks L; Mezquita L; Jovelet C; Planchard D; Auclin E; Remon J; Howarth K; Benitez JC; Gazzah A; Lavaud P; Naltet C; Lacroix L; de Kievit F; Morris C; Green E; Ngo-Camus M; Rouleau E; Massard C; Caramella C; Friboulet L; Besse B
    J Thorac Oncol; 2020 Mar; 15(3):383-391. PubMed ID: 31843682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
    Chae YK; Davis AA; Agte S; Pan A; Simon NI; Iams WT; Cruz MR; Tamragouri K; Rhee K; Mohindra N; Villaflor V; Park W; Lopes G; Giles FJ
    Oncologist; 2019 Jun; 24(6):820-828. PubMed ID: 30867242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 70. Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian
    Shen W; Shan B; Liang S; Zhang J; Yu Y; Zhang Y; Wang G; Bai Y; Qian B; Lu J; Jiang Z
    Pathol Oncol Res; 2021; 27():581534. PubMed ID: 34257528
    [No Abstract]   [Full Text] [Related]  

  • 71. Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study.
    Reichert ZR; Morgan TM; Li G; Castellanos E; Snow T; Dall'Olio FG; Madison RW; Fine AD; Oxnard GR; Graf RP; Stover DG
    Ann Oncol; 2023 Jan; 34(1):111-120. PubMed ID: 36208697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
    Romero A; Serna-Blasco R; Calvo V; Provencio M
    Curr Treat Options Oncol; 2021 Aug; 22(10):86. PubMed ID: 34424428
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF
    Ciardiello D; Boscolo Bielo L; Napolitano S; Martinelli E; Troiani T; Nicastro A; Latiano TP; Parente P; Maiello E; Avallone A; Normanno N; Pisconti S; Nisi C; Bordonaro R; Russo AE; Tamburini E; Toma I; Lotesoriere C; Vallarelli S; Zampino MG; Fazio N; Curigliano G; De Vita F; Ciardiello F; Martini G;
    Ann Oncol; 2024 Aug; ():. PubMed ID: 39214459
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.
    Rolfo CD; Madison RW; Pasquina LW; Brown DW; Huang Y; Hughes JD; Graf RP; Oxnard GR; Husain H
    Clin Cancer Res; 2024 Jun; 30(11):2452-2460. PubMed ID: 38526394
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.
    Belloum Y; Janning M; Mohme M; Simon R; Kropidlowski J; Sartori A; Irwin D; Westphal M; Lamszus K; Loges S; Riethdorf S; Pantel K; Wikman H
    Cells; 2020 Oct; 9(11):. PubMed ID: 33105541
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
    Lonardi S; Nimeiri H; Xu C; Zollinger DR; Madison RW; Fine AD; Gjoerup O; Rasola C; Angerilli V; Sharma S; Wu HT; Palsuledesai CC; Malhotra M; Aleshin A; Loupakis F; Renkonen E; Hegde P; Fassan M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232827
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
    Tomlins SA; Hovelson DH; Suga JM; Anderson DM; Koh HA; Dees EC; McNulty B; Burkard ME; Guarino M; Khatri J; Safa MM; Matrana MR; Yang ES; Menter AR; Parsons BM; Slim JN; Thompson MA; Hwang L; Edenfield WJ; Nair S; Onitilo A; Siegel R; Miller A; Wassenaar T; Irvin WJ; Schulz W; Padmanabhan A; Harish V; Gonzalez A; Mansoor AH; Kellum A; Harms P; Drewery S; Falkner J; Fischer A; Hipp J; Kwiatkowski K; Lazo de la Vega L; Mitchell K; Reeder T; Siddiqui J; Vakil H; Johnson DB; Rhodes DR
    JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.
    Dono M; De Luca G; Lastraioli S; Anselmi G; Dal Bello MG; Coco S; Vanni I; Grossi F; Vigani A; Genova C; Ferrarini M; Ravetti JL; Zupo S
    Mol Med; 2019 Apr; 25(1):15. PubMed ID: 31029076
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circulating tumour DNA in
    Cabanero M; Tsao MS
    Curr Oncol; 2018 Jun; 25(Suppl 1):S38-S44. PubMed ID: 29910646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects.
    Fernandes G; Rodrigues A; Matos C; Barata F; Cirnes L; Ferreira L; Lopes JA; Felizardo M; Fidalgo P; Brito U; Parente B
    Cancer Treat Res Commun; 2023; 36():100725. PubMed ID: 37321073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.